In contrast, during the SR phase, a high level of IL-6 is secreted by the tumour-infiltrating lymphocytes (TILs), antagonizes the effects of TGF-β, and restores the activities of IFN-γ [9]. The gene discussed is TGFB1; the disease is neoplasm.